Innospec (NASDAQ:IOSP – Get Free Report) is one of 296 publicly-traded companies in the “Chemicals” industry, but how does it weigh in compared to its peers? We will compare Innospec to similar companies based on the strength of its analyst recommendations, dividends, earnings, valuation, institutional ownership, profitability and risk.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Innospec and its peers, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Innospec | 1 | 1 | 0 | 0 | 1.50 |
| Innospec Competitors | 3272 | 12238 | 14147 | 520 | 2.39 |
As a group, “Chemicals” companies have a potential upside of 6.71%. Given Innospec’s peers stronger consensus rating and higher possible upside, analysts plainly believe Innospec has less favorable growth aspects than its peers.
Dividends
Earnings & Valuation
This table compares Innospec and its peers revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Innospec | $1.78 billion | $116.60 million | 13.95 |
| Innospec Competitors | $7.96 billion | $229.42 million | 20.21 |
Innospec’s peers have higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Risk & Volatility
Innospec has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, Innospec’s peers have a beta of 0.94, indicating that their average share price is 6% less volatile than the S&P 500.
Profitability
This table compares Innospec and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Innospec | 7.49% | 9.36% | 6.90% |
| Innospec Competitors | -54.07% | -0.31% | -1.28% |
Insider & Institutional Ownership
96.6% of Innospec shares are held by institutional investors. Comparatively, 47.4% of shares of all “Chemicals” companies are held by institutional investors. 1.4% of Innospec shares are held by insiders. Comparatively, 13.7% of shares of all “Chemicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
Innospec peers beat Innospec on 10 of the 15 factors compared.
About Innospec
Innospec Inc. is a global specialty chemicals company that develops and manufactures products for customers in the fuels, oilfield and performance chemicals markets. Its Fuel Specialties business supplies additives for fuels and lubricants, while its Oilfield Services business provides chemical products and services used in oil and gas operations. Through its Performance Chemicals business, Innospec makes specialty ingredients for applications including personal care, home care and agriculture. Its products are used by industrial and consumer-products manufacturers around the world.
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
